Key Statistics
Market Cap$4.85M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$8.62
52W High$35.96
52W Low$0.53
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees21
Price Performance
1 Week-15.00%
3 Month-53.22%
1 Year+405.95%
About
AIM ImmunoTech Inc., an immunpharmaceutical company, focuses on research and development of therapies to treat multiple types of cancers, viruses, and immunodeficiency disorders in the United States. The company is headquartered in Ocala, Florida.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze AIM with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.
